"With 3 doctors voted Best of Atlanta, we are the number one provider of kidney related services in the State of Georgia."

During the past decade, Georgia Nephrology Research Institute conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Georgia Nephrology Research Institute" #1 sponsor was "NephroNet, Inc." with 3 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Anji Pharma" with 1 trials sponsored, "Chinook Therapeutics U.S., Inc." with 1 trials sponsored and "James A. Tumlin, MD" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Georgia Nephrology Research Institute" #1 collaborator was "Mallinckrodt" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Nelson Kopyt, MD" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Georgia Nephrology Research Institute" are "Diabetic Kidney Disease" (2 trials), "Diabetic Nephropathy Type 2" (2 trials), "Alport Syndrome" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Fibrillary Glomerulonephritis" (1 trials). Many other conditions were trialed in "Georgia Nephrology Research Institute" in a lesser frequency.

Most popular intervention types in "Georgia Nephrology Research Institute" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Acthar 80 UNT/ML Injectable Solution" (1 trials), "Acthar Gel 80 UNT/ML Injectable Solution" (1 trials), "Atrasentan" (1 trials), "Filgotinib" (1 trials) and "Filgotinib placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Georgia Nephrology Research Institute" are 8 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Georgia Nephrology Research Institute". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Georgia Nephrology Research Institute, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Georgia Nephrology Research Institute, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".